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Abstract 
Purpose of review: Colorectal cancer is largely preventable with colonoscopy and other 
screening modalities.  However, the effectiveness of screening and surveillance depends on the 
quality of the colonoscopy exam.  Adenoma detection rate is the best-validated metric by which 
we measure individual physicians’ performance.   
Recent findings: As we gather more data on the ADR, we are learning that older benchmarks 
may be inappropriately low.  We have evidence that improving ADR leads to reductions in 
PCCRC.  Two studies have demonstrated that when a colonoscopy is performed by physicians 
with higher ADRs, patients are less likely to have advanced adenomas on the first surveillance 
exam.  Finally, there is at least some evidence that higher ADRs do not lead to more cumulative 
surveillance exams.   
Summary: The ADR is a useful outcome measure that can provide individual endoscopists and 
their patients with information about the likelihood of their patients developing PCCRC.  To 
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achieve the lowest possible PCCRC rate, we should be striving for higher ADRs.  While 
strategies and innovations may help a bit in improving ADRs, our efforts should focus on 
ensuring a complete mucosal exam for each patient.  Behavioral psychology theories may 
provide useful frameworks for studying motivating factors that drive a careful exam.  
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I. Introduction 
 Colonoscopy is performed not just to detect, but to prevent colorectal cancer (CRC).   
Adenomas are precursors to CRC, and the goal of primary prevention, is to remove them before 
they progress to invasive cancer.  Colonoscopy with polypectomy was initially thought to be 
associated with about 80% reduction in CRC incidence; however subsequent adenoma cohort 
studies have shown less impressive results.1  Early estimates of reduction of CRC  incidence 
through removal of adenomas suggested a reduction of about 80%  in cancer incidence, although 
later studies suggested.2, 3  Our patients agree to undergo the invasive procedure because they 
trust that it will protect them from the disease.  However, some physicians are more skilled than 
others at detecting and removing polyps, meaning patients are not equally protected against 
cancers.  Measuring our outcomes can help us estimate the level of protection we provide and 
can motivate us to improve.  The “ultimate” outcome is CRC mortality; fortunately, few 
endoscopists have enough patients in surveillance programs who die of CRC for mortality to be a 
useful measure of effectiveness, or a quality metric suitable for interventions.  We therefore must 
use surrogate measures that provide us with more immediate data but that correlate with the 
ultimate outcome of CRC mortality.   
II. The adenoma detection rate 
 The best-established surrogate outcome measure is the adenoma detection rate (ADR).  
The ADR is “the proportion of screening colonoscopies performed by a physician that detect at 
least one histologically confirmed colorectal adenoma or adenocarcinoma.”4  Initially only 
screening exams were used to calculate ADR, because we didn’t want to contaminate our 
screening population with the effect of surveillance exams.  Since then, we have learned that 
using a mix of screening and surveillance populations yields similar results as using exclusively 
screening populations when calculating ADR.  There was concern that “indication gaming” 
might tempt some endoscopists to select the procedure indication as “screening” whenever he or 
she was confident that an adenoma had been removed, while using another indication if it was 
present and an adenoma had not been removed.  However, when Rex and colleagues measured 
ADR using indication gaming and using true indications, they found that the ADR was similar in 
both measurement methods.5   
 The ADR is useful because it correlates with the post-colonoscopy colorectal cancer 
(PCCRC) rate.6  A PCCRC interval cancer is a cancer that is diagnosed after a screening or 
surveillance examination in which no cancer is detected, and before the date of the next 
recommended examination.7  In a landmark study, Corley and colleagues examined the 
correlation between ADR and risk of PCCRC death.  They found that “physicians who increase 
their ADR from <19% to >34% might prevent 1 additional interval cancer over the next 10 years 
for every 213 colonoscopies performed,” and that “each 1% increase in ADR was associated 
with a 5% decrease in the risk of a fatal interval CRC within the observed range of ADRs.”4   
Samadder and colleagues found that 6% of colon cancers detected were in patients who 
had had a colonoscopy at least six months but fewer than 5 years prior to the cancer diagnosis, 
which suggests that 6% of cancers detected were interval cancers.8  le Clerq and colleagues 
found that 86.4% of 147 PCCRCs were related to procedural factors (incomplete resection, 
missed lesions, inadequate exam/surveillance), while only 13% were truly aggressive cancers.9  
Robertson and colleagues found that 71% of 58 PCCRCs were related to procedural factors, 
while 24% were aggressive cancers.10  Taken together, these data imply that improving 
procedural quality could bring the PCCRC rate closer to the theoretical minimum of 0.78-1.4% 
of cancers.  
Kim and colleagues found that in patients with one or two adenomas, a low ADR for the 
endoscopist performing the baseline screening was as significant a risk factor for metachronous 
cancer as the number, size, and histology of adenomas at baseline.11  However, patients with no 
adenomas at screening had such a low risk of metachronous cancer that the endoscopist’s ADR 
did not matter.  This supports the findings by Robertson and colleagues that most of the risk of 
PCCRC comes from missed lesions, incomplete polypectomy, and improper surveillance 
intervals.12   
 
III. What is an adequate ADR? 
Older American guidelines suggested that the ADR should be at least 15% in women and 
25% in men.13  As high-definition colonoscopes and multiple technological advances have come 
into use, much higher ADRs have been demonstrated in the recent literature.  Kaminski and 
colleagues in 2017 divided their endoscopists into quartiles.  The best group had a mean ADR of 
31.3%, and the worst had mean of 10.8%.14  Their study population developed 168 interval 
cancers in 895,916 person-years of follow up, representing 10.1% of all cancers detected during 
a 5-year follow up.  They found that those endoscopists who increased their ADR from the 
lowest to the highest quartile decreased their interval cancer rate from 25.3 cases/100,000 
patient-years to 7.1 cases/100,000 patient-years.14  They showed that a benchmark of 24.6% was 
the threshold needed to reach a “profound and statistically significant reduction in the risk of 
interval colorectal cancer.”   
European performance measures indicate a minimum ADR of >=25% when looking at all 
colonoscopies in patients 50 years and older, excluding emergencies and therapeutic indications; 
screening and surveillance exams are included together.15  Multiple studies have demonstrated 
that the ADR is higher in women physicians, gastroenterologists, and those with 9 or fewer years 
since residency training.16  The total ADR may not tell the whole story, as James and colleagues 
measured distal and proximal ADR for endoscopists and found that they are only modestly 
correlated.17 
So far, no study has found a “ceiling” for ADR, but there appears to be a steady decrease 
in interval cancer rate as ADR increases.  Shaukat and colleagues developed a nonlinear Poisson 
regression model plotting the relationship between physicians’ ADRs and the incidence of 
PCCRC.18  It appears that the plateau for ADR is between 50-60%; at this level, the incidence of 
PCCRC appears to be less than one cancer per 10,000 person-years.  This appears to be 
significantly lower than what would be estimated based on CRC incidence data.  The incidence 
of colorectal cancer was 40.7/100,000 person-years between 2009-2013.19  Using estimates that 
13-24% of interval cancers are aggressive and not due to procedural factors, we would expect 
that an endoscopist who performs 500 colonoscopies per year for 10 years might see 0.3-0.56 
PCCRCs that he or she could not have prevented.  Because an ADR of 50% seems to correlate 
with a PCCRC rate lower than this estimated minimum, then 50% is probably a good estimate of 
the “ideal”, “aspirational”, or “ceiling” ADR. 
 IV. How does ADR affect the surveillance interval? 
 It is likely that endoscopists with very high ADRs are detecting more diminutive 
adenomas that are not necessarily clinically significant.  This could lead to more frequent 
surveillance exams where little pathology is detected, increasing costs and risks without clear 
clinical benefit.  Instead, we believe that finding diminutive polyps and taking the time to 
remove them is a marker of a more thorough exam. 
 The colonoscopist’s ADR affects the yield of future colonoscopies.  Mangas-Sanjuan and 
colleagues studied a higher-risk group, which was a cohort of patients who had an advanced 
adenoma detected on index exam.  They found that the ADR of the colonoscopist who performed 
the baseline exam predicted finding advanced neoplasia at surveillance colonoscopy.20  Kim and 
colleagues studied a lower-risk group, which was patients who had no or only 1 or 2 non-
advanced adenomas at a baseline exam.11  They showed that when compared to physicians with a 
low ADR, if the physician performing an initial screening exam has a moderate or high ADR, 
and at least one adenoma was found at baseline, it was about 2/3 less likely that any neoplasia or 
an advanced adenoma would be found at the next surveillance exam.  This effect did not reach 
statistical significance if no adenomas were found during the baseline exam.  In this study, the 
“hidden risk” group, which had the highest risk of advanced neoplasia at follow up exam, had 
two adenomas on their initial exam and had their initial exam performed by a physician with a 
low ADR.  Taken together, these studies suggest that unless the index exam is negative, the ADR 
of the endoscopist should impact our surveillance recommendations.  Conversely, if an exam is 
performed by a physician who has a high ADR, we may be able to lengthen the screening 
interval.21 
When a colonoscopy is performed by a physician with a high ADR, there are two 
implications.  First, it is more likely that one or more polyps will be found, which will shorten 
the surveillance interval from 10 to 5 or even 3 years.  Second, it is less likely that a polyp will 
be left behind, which implies that the yield of the next exam will be lower.  These patients are 
doubly protected; physicians with a high ADR protect their patients both by removing all 
pathology and by recommending shorter surveillance intervals.  Physicians with a low ADR do 
their patients a double disservice, by missing pathology and by recommending inappropriately 
longer surveillance intervals.  Conversely, some physicians seem to be aware that they are at risk 
of missing pathology and recommend shorter surveillance intervals than guidelines would 
recommend after a negative exam.  It is not clear what effect these practice patterns have on 
PCCRC risk.  
 
V. Other measures of colonoscopy quality 
In addition to the ADR and the PCCRC rate, other measures have been proposed or used 
as markers of colonoscopy quality.  “Adenomas per colonoscopy” (APC) has been suggested by 
an ACG/ASGE joint task force.22  When ADR is measured, some physicians will search less 
aggressively for polyps after the first adenoma is found,23 as removing additional polyps will 
lengthen the procedure without improving the ADR.  The APC would reduce this tendency.  
However, to measure APC accurately, each polyp would need to be examined separately to 
confirm that it is an adenoma.  This could generate increased costs for photography software or 
pathology.  Hilsden and colleagues found that the ADR and APC were complementary; APC did 
a better job of discriminating between the lowest- and highest-performing endoscopists, but 
some endoscopists achieved minimum benchmarks on one measure but not the other.24  
Routinely reporting both measures may act as a motivating factor for physicians who are above 
the ADR benchmark but have room for improvement. 
In the United States, withdrawal time (WT) is frequently tracked , which is the amount of 
time a physician spends examining the colonic mucosa after intubation and identification and 
photo documentation of the cecum landmarks of appendicular orifice and ileocecal valve, until 
the endoscope is withdrawn from the anus.2  Currently, WT is best used as a target for 
intervention for endoscopists who have low ADRs and short WTs. European performance 
measures include numerous pre- and post-procedure factors, such as bowel preparation, time slot 
for colonoscopy, polyp detection rate, appropriate polypectomy technique, polyp retrieval rate, 
tattooing resection sites, complication rate, patient experience, and appropriate post-polypectomy 
surveillance.15  The advanced adenoma detection rate has been suggested, with the rationale that 
these are more clinically meaningful lesions.  However, size measurements are somewhat 
subjective.5  “Polyp detection rate” can be used, but this measurement can be gamed by 
removing clinically insignificant polyps.5  The serrated polyp detection rate has also been 
considered, as serrated lesions are more difficult to detect and contribute significantly to 
PCCRC.  This measurement is problematic, however, because serrated neoplasia detection tends 
to correlate with that of adenomas especially for high-level detectors, and because of the 
significant inter-observer variability among pathologists in the interpretation of subtypes of 
serrated polyps. 
 
VI. How can a physician improve his or her ADR? 
 Some factors associated with a higher ADR are immutable, such as being female, being a 
gastroenterologist, and being in practice for less than nine years.16  However, other factors can be 
changed.  A combination of feedback, benchmarking and training has been most effective in 
improving ADRs.  Many physicians improve gradually over time when they know they are being 
monitored. For example, multiple studies using performance feedback have shown that ADR 
improves steadily throughout the duration of the tracking period.21, 25  A meticulous and 
compulsive mucosal inspection technique is critical.  Interestingly, attempts at re-training after 
entering practice have been met with mixed results.  Interventions that have been studied to 
determine the effect on improving ADR are summarized in Table 1.  There is insufficient 
evidence to recommend for or against the use of specific bowel preparations, CO2 insufflation, 
Propofol sedation, antispasmodics, or position changes for the purpose of improving ADR. 
 
 
 
 
 
 
VII. Negative effects of increasing ADR 
 
 While the GI field is focused on improving the ADR, there are some potential downsides 
to this goal.  Modeling has projected an increased burden of surveillance endoscopies that are 
recommended after adenoma removal.14  However, in the study by Mangas-Sanjuan and 
colleagues, a high ADR was not associated with more frequent surveillance.20  Procedure times 
may be longer due to time spent on careful mucosal inspection and on removing pathology.  The 
clinical benefit of removing diminutive polyps is not clear, since the vast majority of these will 
not progress to invasive cancer.  Patients may experience anxiety after being labelled “high-risk” 
when more than two adenomas are found, as current guidelines recommend the same 
surveillance interval for patients with a few diminutive adenomas as for those with a 
histologically advanced adenoma.  Finally, there is the concern  about  increased complication 
rates due to more frequent  surveillance exams; however, in multiple studies, the perforation rate 
was the same for those who improved ADR and those who did not (0.02% for both groups).14  
Furthermore, Brenner and colleagues found that as ADR improved, bleeding and perforation 
rates were stable over 10 years.21   
 
VIII. Why do some physicians lack motivation to improve? 
 If there are so many methods available that help improve the ADR, why do some 
individual physicians not adopt them?  A number of factors might be at play.  Michie and 
colleagues studied psychological theories that influence behavior change when implementing 
evidence-based medicine guidelines.  They developed a list of 12 domains that could be studied 
to learn more about behavior change.26  This study illustrates that informing physicians about the 
importance of a practice and ensuring that they have the skills to change their behavior are only 
part of the process; many additional factors determine whether they will implement the change.  
For example, if physicians lack the self-efficacy to believe that they are capable of achieving an 
ADR of 50%, it is unlikely that they will make significant efforts toward achieving that goal.  If 
the endoscopy unit environment is not designed to allow for ample withdrawal times, then 
competing pressures will outweigh physicians’ motivation to spend more time examining.  If 
group norms in the environment stress productivity over ADR and other metrics, physicians will 
strive for higher productivity.  It has also been proposed that obsessive-compulsive or other 
personality traits may be more prominent in endoscopists with a high ADR, and these traits are 
more difficult to impact. 
 For those who are not receiving feedback in the form of ADR, withdrawal times, or 
interval cancer rates, the Dunning-Kruger effect might be playing a role.27  In the studies 
conducted by Dunning & Kruger, subjects assessed their own skills as being about average when 
they were significantly below average.  This finding suggests that endoscopists who have a 
below-average ADR may not believe their skills are inferior to their colleagues’ skills. 
 For those who are aware that their ADR is below average but choose not to adopt new 
methods or technology to improve their skills, it may be difficult to see the benefit of improving 
the ADR.  For example, Kaminski and colleagues found that endoscopists who increased their 
ADR from the lowest (10.8%) to the highest quartile (31.1%) decreased their interval cancer rate 
from 25.3 cases/100,000 patient-years to 7.1 cases/100,000 patient-years.14  The event of an 
interval cancer is so rare that an individual endoscopist is very unlikely to notice a difference 
after improving his/her ADR.  The benefit is seen at the population level, when the pool of 
physicians improves its collective ADR.  When weighing the cost of additional training, 
additional equipment, and the additional time they would spend on each exam doing a more 
thorough mucosal examination, many physicians cannot perceive the benefit of a possibly seeing 
a few fewer interval cancers as justifying those costs.  Furthermore, the cost of treating invasive 
cancer would be borne by the patient/insurance company, not by the endoscopist.  In his 
landmark work on game theory, Thomas Schelling wrote of the difficulty convincing people to 
act to benefit the greater good when they are motivated by personal reward.28  Daniel 
Kanneman’s theory of loss aversion also partially explains this.  He argues that it is difficult for 
people to choose to act when the outcome being prevented is in the future, the effects are 
uncertain, and the action involves personal cost.29  Certainly the outcome of a PCCRC would fit 
these criteria.  
 Because the outcome of interval cancer is so rare, and because physicians may not even 
learn of an interval cancer found in their patients, surrogate outcomes such as ADR and 
withdrawal time are used for more immediate feedback.  However, if physicians do not 
appreciate the correlation between these surrogate markers and PCCRCs, they may place less 
importance on improving these measures.  Indeed, there are “ADR deniers” who may be 
skeptical that it is a useful metric and disregard their audit data.  This can likely be explained 
using some of the behavioral psychology theories described above, but further study of this 
might help inform future interventions. 
 
IX. Conclusion - The future of screening 
In the ideal situation, the ADR would inform screening and surveillance 
recommendations, in addition to patient risk factors and colonoscopy findings. A screening 
colonoscopy done by a physician who has an aspirational ADR imparts a high degree of 
protection against CRC.  If no adenomas are found, the patient can avoid another exam for at 
least 10 years, and if adenomas are found, then surveillance intervals longer than the 
conventional 3 or 5 years can be considered, based on details of adenoma findings.  If the initial 
exam is performed by a physician with an ADR just above established benchmarks, then 
established screening and surveillance intervals would need to be followed.  More research is 
needed before recommendations could be provided if the initial exam is performed by a 
physician who does not meet minimum benchmarks.   
Future studies might explore the best surveillance interval after a colonoscopy is 
performed by a physician with an aspirational ADR.  It would also be valuable to apply 
behavioral psychology theories to the practice of colonoscopy; learning how to motivate 
physicians to perform a complete mucosal exam could have a major impact on the PCCRC rate.   
X. Key points 
• The adenoma detection rate (ADR) is now well-established as a marker of risk for post-
colonoscopy colorectal cancer (PCCRC). 
• Improving one’s ADR is correlated with a reduction in the PCCRC rate. 
• Existing benchmarks for adequate ADRs may be too low to provide adequate protection 
from PCCRC. 
• While techniques and technology are available that make minor contributions to 
improving ADR, the most important factor is a complete mucosal exam.  
• Behavioral psychology theories may provide useful frameworks for studying factors that 
motivate endoscopists to perform a careful exam.  
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Table – Interventions aimed at improving ADR (original) 
Method Population studied Effect on ADR Limitations 
Training in 
withdrawal technique 
and lesion 
identification 
EQUIP 1 & 2 - Average 
ADR 36% 
ADR improved to 47%30 and 
remained improved after 5 
months.31 
 
EQUIP-3 – Average 
ADR 31% in the 
intervention group, 36% 
in the control group 
ADR improved by 12% in the 
intervention group, but 
endoscopists receiving passive 
monitoring improved by 4%.32 
 
Mandating a 
minimum withdrawal 
time for each of four 
segments 
Single-center study, 
physicians were asked to 
spend at least 2 minutes 
per colon segment 
Mean ADR improved from 
23.5% before to 34.7% after the 
intervention.33 
Mandating a 
withdrawal time 
for the whole 
exam has not 
led to 
improvements 
in ADR.  
Instead, 
endoscopists 
should focus on 
mastering the 
technique of 
effective 
mucosal 
exposure, as this 
will naturally 
lead to longer 
withdrawal 
times.34 
Switching to high-
definition 
endoscopes 
Meta-analysis; mixed 
population 
incremental yield of 3.5% for 
small adenomas but not for 
larger or more advanced 
neoplasia. 2 
 
Use of narrow band 
imaging 
Control ADR of 34.4% ADR improved to 48.3% in 190-
NBI group.  Polyp detection also 
increased, without a difference 
in adenoma miss rate.35 
 
NBI on older 
scopes was 
darker and not 
as effective 
Dye-based 
Chromoendoscopy 
Meta-analysis (mixed 
population) 
increase of 30% (0.33 lesions) in 
adenoma detection, but with 
increased cost and procedure 
duration36 
Only one study 
used high-
definition 
colonoscopes as 
controls 
Water exchange 
colonoscopy 
Baseline ADR not 
reported 
Higher ADR with water 
immersion/exchange vs. air 
(36.3% vs. 31.4%)37 
 
Second examination 
of the right colon 
(either retroflexed or 
in forward view) 
30.2-34% on first pass 7.5% had an additional adenoma 
in retroflexion, 10.5% had an 
additional adenoma on 2nd 
forward view exam; there was 
no difference between 
techniques38 
mean 
withdrawal time 
in these studies 
was 12.5 
minutes, so it is 
possible that the 
increased ADR 
is related to a 
longer 
withdrawal time 
and not 
necessarily to 
the method of 
examination 
Reporting ADR to 
physicians 
Tertiary-care VA with 
six physicians 
Mean ADR increased from 
44.7% before to 53.9% after 
implementing quarterly report 
cards.25 
 
Leadership training Polish study where 
center leaders underwent 
intensive training 
ADR for not just the participant 
leaders, but for the facilities led 
by participants improved from a 
mean of 18.4% to 24.1%.39 
 
Cap-assisted 
colonoscopy 
Board-certified 
gastroenterologists at 
two centers (one VA), 
using 180 scopes 
No difference in ADR between 
cap-assisted or standard exam 
(60% vs. 57%)40 
 
Endocuff Meta-analysis of studies 
from multiple 
international sites, but 
mostly academic 
hospitals 
ADR in Endocuff group was 
50.4%, compared to 43.3% in 
standard colonoscopy group.41 
It appears that 
the Endocuff 
was more useful 
in groups where 
the control ADR 
was lower.  The 
device has 
subsequently 
been replaced 
by the Endocuff 
Vision, which 
has not been 
extensively 
studied. 
Single-center RCT in 
the UK 
No significant difference 
between ADR in Endocuff 
group (60.9%) and standard 
group (63.0%).42 
FUSE Regional screening 
program of FIT-positive 
patients 
No significant difference in 
ADR between FUSE (43.6%) 
and standard forward view 
(45.5%).43 
Several other 
devices are 
available 
(mostly outside 
the US) to 
improve the 
field of view, 
and these 
generally result 
in an 
improvement in 
ADR by about 
7%, but the cost 
of these devices 
precludes 
routine use.34   
 
